Associated Papers
Analysis of Anakinra Therapy for the Deficiency of Interleukin-1 Receptor Antagonist through Clinical Evidence.
Pillai K et al.
Journal of Clinical Medicine, 2024
Case report: Novel compound heterozygous IL1RN mutations as the likely cause of a lethal form of deficiency of interleukin-1 receptor antagonist.
Urbaneja E et al.
Frontiers in Immunology, 2024
Novel mutation in interleukin 1 receptor antagonist associated with chronic diarrhoea in infancy.
Abdwani R et al.
Journal of Paediatrics and Child Health, 2022
Inborn Errors of Immunity With Fetal or Perinatal Clinical Manifestations.
Carneiro-Sampaio M et al.
Frontiers in Pediatrics, 2022
A case report of a novel compound heterozygous mutation in a Brazilian patient with deficiency of Interleukin-1 receptor antagonist (DIRA).
Mendonça LO et al.
Pediatric Rheumatology Online Journal, 2020
Monogenic Autoinflammatory Diseases with Mendelian Inheritance: Genes, Mutations, and Genotype/Phenotype Correlations.
Martorana D et al.
Frontiers in Immunology, 2017
Interleukin-1 receptor antagonist deficiency with a novel mutation; late onset and successful treatment with canakinumab: a case report.
Ulusoy E et al.
Journal of Medical Case Reports, 2015
Working the endless puzzle of hereditary autoinflammatory disorders.
Caso F et al.
Modern Rheumatology, 2014
A novel mutation in the interleukin-1 receptor antagonist associated with intrauterine disease onset.
Altiok E et al.
Clinical Immunology (orlando, Fla.), 2012
Select a paper to view details